Literature DB >> 26857578

Porphyromonas gingivalis Outer Membrane Vesicles Induce Selective Tumor Necrosis Factor Tolerance in a Toll-Like Receptor 4- and mTOR-Dependent Manner.

Tobias Waller1,2, Laura Kesper1, Josefine Hirschfeld1,2, Henrik Dommisch2,3, Johanna Kölpin1, Johannes Oldenburg4, Julia Uebele1,5, Achim Hoerauf1, James Deschner6, Sören Jepsen2, Isabelle Bekeredjian-Ding7,5.   

Abstract

Porphyromonas gingivalis is an important member of the anaerobic oral flora. Its presence fosters growth of periodontal biofilm and development of periodontitis. In this study, we demonstrated that lipophilic outer membrane vesicles (OMV) shed from P. gingivalis promote monocyte unresponsiveness to live P. gingivalis but retain reactivity to stimulation with bacterial DNA isolated from P. gingivalis or AIM2 ligand poly(dA·dT). OMV-mediated tolerance of P. gingivalis is characterized by selective abrogation of tumor necrosis factor (TNF). Neutralization of interleukin-10 (IL-10) during OMV challenge partially restores monocyte responsiveness toP. gingivalis; full reactivity toP. gingivalis can be restored by inhibition of mTOR signaling, which we previously identified as the major signaling pathway promoting Toll-like receptor 2 and Toll-like receptor 4 (TLR2/4)-mediated tolerance in monocytes. However, despite previous reports emphasizing a central role of TLR2 in innate immune recognition of P. gingivalis, our current findings highlight a selective role of TLR4 in the promotion of OMV-mediated TNF tolerance: only blockade of TLR4-and not of TLR2-restores responsiveness toP. gingivalis Of further note, OMV-mediated tolerance is preserved in the presence of cytochalasin B and chloroquine, indicating that triggering of surface TLR4 is sufficient for this effect. Taking the results together, we propose that P. gingivalis OMV contribute to local immune evasion of P. gingivalis by hampering the host response.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26857578      PMCID: PMC4807478          DOI: 10.1128/IAI.01390-15

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  63 in total

1.  Vesicle-mediated export and assembly of pore-forming oligomers of the enterobacterial ClyA cytotoxin.

Authors:  Sun Nyunt Wai; Barbro Lindmark; Tomas Söderblom; Akemi Takade; Marie Westermark; Jan Oscarsson; Jana Jass; Agneta Richter-Dahlfors; Yoshimitsu Mizunoe; Bernt Eric Uhlin
Journal:  Cell       Date:  2003-10-03       Impact factor: 41.582

2.  On the origin of membrane vesicles in gram-negative bacteria.

Authors:  L Zhou; R Srisatjaluk; D E Justus; R J Doyle
Journal:  FEMS Microbiol Lett       Date:  1998-06-15       Impact factor: 2.742

3.  Lipopolysaccharides from periodontopathic bacteria Porphyromonas gingivalis and Capnocytophaga ochracea are antagonists for human toll-like receptor 4.

Authors:  Atsutoshi Yoshimura; Takashi Kaneko; Yoshifumi Kato; Douglas T Golenbock; Yoshitaka Hara
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

4.  Differential induction of endotoxin tolerance by lipopolysaccharides derived from Porphyromonas gingivalis and Escherichia coli.

Authors:  M Martin; J Katz; S N Vogel; S M Michalek
Journal:  J Immunol       Date:  2001-11-01       Impact factor: 5.422

5.  Rapamycin enhances LPS induction of tissue factor and tumor necrosis factor-alpha expression in macrophages by reducing IL-10 expression.

Authors:  Alyson K Baker; Ruipeng Wang; Nigel Mackman; James P Luyendyk
Journal:  Mol Immunol       Date:  2009-05-17       Impact factor: 4.407

6.  Identification of signaling pathways in macrophage exposed to Porphyromonas gingivalis or to its purified cell wall components.

Authors:  Qingde Zhou; Salomon Amar
Journal:  J Immunol       Date:  2007-12-01       Impact factor: 5.422

Review 7.  The immunobiology of toll-like receptor 4 agonists: from endotoxin tolerance to immunoadjuvants.

Authors:  Julia K Bohannon; Antonio Hernandez; Perenlei Enkhbaatar; William L Adams; Edward R Sherwood
Journal:  Shock       Date:  2013-12       Impact factor: 3.454

8.  Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTOR-p70S6K pathway.

Authors:  Weiping Cao; Santhakumar Manicassamy; Hua Tang; Sudhir Pai Kasturi; Ali Pirani; Niren Murthy; Bali Pulendran
Journal:  Nat Immunol       Date:  2008-08-31       Impact factor: 25.606

9.  Human Toll-like receptor 4 responses to P. gingivalis are regulated by lipid A 1- and 4'-phosphatase activities.

Authors:  Stephen R Coats; Jace W Jones; Christopher T Do; Pamela H Braham; Brian W Bainbridge; Thao T To; David R Goodlett; Robert K Ernst; Richard P Darveau
Journal:  Cell Microbiol       Date:  2009-06-13       Impact factor: 3.715

10.  Porphyromonas gingivalis manipulates complement and TLR signaling to uncouple bacterial clearance from inflammation and promote dysbiosis.

Authors:  Tomoki Maekawa; Jennifer L Krauss; Toshiharu Abe; Ravi Jotwani; Martha Triantafilou; Kathy Triantafilou; Ahmed Hashim; Shifra Hoch; Michael A Curtis; Gabriel Nussbaum; John D Lambris; George Hajishengallis
Journal:  Cell Host Microbe       Date:  2014-06-11       Impact factor: 21.023

View more
  13 in total

1.  Outer Membrane Vesicle-Host Cell Interactions.

Authors:  Jessica D Cecil; Natalie Sirisaengtaksin; Neil M O'Brien-Simpson; Anne Marie Krachler
Journal:  Microbiol Spectr       Date:  2019-01

2.  Porphyromonas gingivalis Cell Wall Components Induce Programmed Death Ligand 1 (PD-L1) Expression on Human Oral Carcinoma Cells by a Receptor-Interacting Protein Kinase 2 (RIP2)-Dependent Mechanism.

Authors:  S Groeger; F Denter; G Lochnit; M L Schmitz; J Meyle
Journal:  Infect Immun       Date:  2020-04-20       Impact factor: 3.441

Review 3.  Gingimaps: Protein Localization in the Oral Pathogen Porphyromonas gingivalis.

Authors:  Giorgio Gabarrini; Stefano Grasso; Arie Jan van Winkelhoff; Jan Maarten van Dijl
Journal:  Microbiol Mol Biol Rev       Date:  2020-01-02       Impact factor: 11.056

4.  Interspecies Communication between Pathogens and Immune Cells via Bacterial Membrane Vesicles.

Authors:  Katerina S Jurkoshek; Ying Wang; Jaffre J Athman; Marian R Barton; Pamela A Wearsch
Journal:  Front Cell Dev Biol       Date:  2016-11-11

Review 5.  Porphyromonas gingivalis suppresses adaptive immunity in periodontitis, atherosclerosis, and Alzheimer's disease.

Authors:  Ingar Olsen; Martin A Taubman; Sim K Singhrao
Journal:  J Oral Microbiol       Date:  2016-11-22       Impact factor: 5.474

6.  Expression of Tumor Necrosis Factor Receptor 2 Characterizes TLR9-Driven Formation of Interleukin-10-Producing B Cells.

Authors:  Olga Ticha; Lukas Moos; Harald Wajant; Isabelle Bekeredjian-Ding
Journal:  Front Immunol       Date:  2018-01-19       Impact factor: 7.561

Review 7.  TNF Tolerance in Monocytes and Macrophages: Characteristics and Molecular Mechanisms.

Authors:  René Huber; Rolf Bikker; Bastian Welz; Martin Christmann; Korbinian Brand
Journal:  J Immunol Res       Date:  2017-11-08       Impact factor: 4.818

8.  Isolation of membrane vesicles from prokaryotes: a technical and biological comparison reveals heterogeneity.

Authors:  Priscila Dauros Singorenko; Vanessa Chang; Alana Whitcombe; Denis Simonov; Jiwon Hong; Anthony Phillips; Simon Swift; Cherie Blenkiron
Journal:  J Extracell Vesicles       Date:  2017-06-06

9.  Metabolic Remodeling, Inflammasome Activation, and Pyroptosis in Macrophages Stimulated by Porphyromonas gingivalis and Its Outer Membrane Vesicles.

Authors:  Andrew J Fleetwood; Man K S Lee; William Singleton; Adrian Achuthan; Ming-Chin Lee; Neil M O'Brien-Simpson; Andrew D Cook; Andrew J Murphy; Stuart G Dashper; Eric C Reynolds; John A Hamilton
Journal:  Front Cell Infect Microbiol       Date:  2017-08-04       Impact factor: 5.293

Review 10.  Mechanisms of outer membrane vesicle entry into host cells.

Authors:  Eloise J O'Donoghue; Anne Marie Krachler
Journal:  Cell Microbiol       Date:  2016-09-16       Impact factor: 3.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.